Q/C Technologies, Inc. Stock Issued During Period, Shares, Reverse Stock Splits
Q/C Technologies, Inc. (QCLS) had Stock Issued During Period, Shares, Reverse Stock Splits of 16.67 million shares as of 2024-02-14, per its 10-Q filed 2025-05-15.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2025-05-15
- 2024-02-14: Stock Issued During Period, Shares, Reverse Stock Splits 16.67M shares.
- 2024-02-13: Stock Issued During Period, Shares, Reverse Stock Splits 500.00M shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits |
|---|---|
| 2024-02-14 | 16.67M shares 10-Q · filed 2025-05-15 |
| 2024-02-13 | 500.00M shares 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |